I'm looking at a bear call spread that assumes Datadog will struggle to get above the 150 level between now and the end of ...

Whatever the case, the fundamentals of a politically supportive backdrop for Novavax’s traditional approach to vaccines could easily boost NVAX stock under Trump’s second administration. With that in ...

ICU Medical's shares soared in 2024 with a strong rebound forecast. Read why ICUI stock remains intriguing for investors amid ...

By trading at a significant discount to its 2022 highs, Pfizer stock now offers investors a rare opportunity to buy this industry giant at a discount. Besides the price action, discounts are coming ...

Sangamo is on course to run out of money within months and has now lost access to up to $220 million in milestone payments ...

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the ...

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to ...

After years of almost constant struggle, one crisis after another, the financial markets finally got some respite in 2024.

The equity is pulling back slightly today, though it remains well above its Nov. 15 dip to $24.48 -- its lowest mark since ...

Today, Benzinga 's options scanner spotted 9 uncommon options trades for Pfizer. This isn't normal. The overall sentiment of ...

Why Kirk Spano sees Pfizer as one of the next big winners from AI and why he thinks investors should be selling cash secured ...

Plenty of high-performing growth stocks pay dividends -- such as Apple and Nvidia -- and though their dividend yields can be ...